Display options
Cite
Burgess IF. Re: Treatment of Parasitic Skin Diseases with Dimeticones A New Family of Compounds with a Purely Physical Mode of Action. Trop Med Health. 2015;43(2):89-90doi: 10.2149/tmh.2014-39.
Burgess, I. F. (2015). Re: Treatment of Parasitic Skin Diseases with Dimeticones A New Family of Compounds with a Purely Physical Mode of Action. Tropical medicine and health, 43(2), 89-90. https://doi.org/10.2149/tmh.2014-39
Burgess, Ian F. "Re: Treatment of Parasitic Skin Diseases with Dimeticones A New Family of Compounds with a Purely Physical Mode of Action." Tropical medicine and health vol. 43,2 (2015): 89-90. doi: https://doi.org/10.2149/tmh.2014-39
Burgess IF. Re: Treatment of Parasitic Skin Diseases with Dimeticones A New Family of Compounds with a Purely Physical Mode of Action. Trop Med Health. 2015 Jun;43(2):89-90. doi: 10.2149/tmh.2014-39. Epub 2015 Jan 31. PMID: 26060419; PMCID: PMC4442775.
Copy Download .nbib Format: NLM
Share it on

Trop Med Health. 2015 Jun;43(2):89-90. doi: 10.2149/tmh.2014-39. Epub 2015 Jan 31.

Re: Treatment of Parasitic Skin Diseases with Dimeticones A New Family of Compounds with a Purely Physical Mode of Action.

Tropical medicine and health

Ian F Burgess

Affiliations

  1. Insect Research & Development Limited , 6 Quy Court, Colliers Lane, Stow-Cum-Quy, Cambridge, Cambridgeshire, CB25 9AU, U.K.

PMID: 26060419 PMCID: PMC4442775 DOI: 10.2149/tmh.2014-39

Abstract

The article on use of dimeticone for treatment of epidermal parasitic skin diseases is potentially confusing and misleading because, in a practical sense, only head louse infestation can be treated with this material. Scabies mites are unaffected by silicones and use of dimeticone against other ectoparasites may have unwanted side effects such as anaphylactiform reactions or increased risk of pathogen transmission.

Keywords: Ectoparasites; dimeticone; treatment

References

  1. Trop Med Health. 2014 Jun;42(2 Suppl):15-20 - PubMed
  2. PLoS Negl Trop Dis. 2014 Jul 31;8(7):e3058 - PubMed
  3. BMJ. 2005 Jun 18;330(7505):1423 - PubMed
  4. BMC Infect Dis. 2008 Sep 10;8:115 - PubMed
  5. Arzneimittelforschung. 2008;58(5):248-54 - PubMed
  6. BMC Pharmacol. 2009 Feb 20;9:3 - PubMed

Publication Types